Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD45R/B220 expression on mouse lymphocytes. BALB/c mouse splenic leucocytes were stained with Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085/553086) followed by BD Horizon™ BV421 Streptavidin/SAV (Cat. No. 563259; solid line histogram) or with BD Horizon™ BV421 Streptavidin alone (dashed line histogram). Flow cytometric histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSRII System.
Immunohistofluorescent analysis of CD45R/B220 expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and blocked with 5% goat serum and 1% BSA diluted in 1x PBS. The sections were then treated with an Avidin/Biotin Blocking Kit (Vector Laboratories), and stained with Alexa Fluor® 488 Rat Anti-Mouse CD4 antibody (Cat. No. 557667, pseudo-colored blue), Alexa Fluor® 647 Rat Anti-Mouse CD8a antibody (Cat. No. 557682, pseudo-colored red), and Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085). After washing, sections were then stained with BD Horizon™ BV421 Streptavidin secondary reagent (Cat. No. 563259, pseudo-colored green). Images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Flow cytometric analysis of CD45R/B220 expression on mouse lymphocytes. BALB/c mouse splenic leucocytes were stained with Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085/553086) followed by BD Horizon™ BV421 Streptavidin/SAV (Cat. No. 563259; solid line histogram) or with BD Horizon™ BV421 Streptavidin alone (dashed line histogram). Flow cytometric histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSRII System.
Immunohistofluorescent analysis of CD45R/B220 expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and blocked with 5% goat serum and 1% BSA diluted in 1x PBS. The sections were then treated with an Avidin/Biotin Blocking Kit (Vector Laboratories), and stained with Alexa Fluor® 488 Rat Anti-Mouse CD4 antibody (Cat. No. 557667, pseudo-colored blue), Alexa Fluor® 647 Rat Anti-Mouse CD8a antibody (Cat. No. 557682, pseudo-colored red), and Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085). After washing, sections were then stained with BD Horizon™ BV421 Streptavidin secondary reagent (Cat. No. 563259, pseudo-colored green). Images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Flow cytometric analysis of CD45R/B220 expression on mouse lymphocytes. BALB/c mouse splenic leucocytes were stained with Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085/553086) followed by BD Horizon™ BV421 Streptavidin/SAV (Cat. No. 563259; solid line histogram) or with BD Horizon™ BV421 Streptavidin alone (dashed line histogram). Flow cytometric histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSRII System.
Immunohistofluorescent analysis of CD45R/B220 expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and blocked with 5% goat serum and 1% BSA diluted in 1x PBS. The sections were then treated with an Avidin/Biotin Blocking Kit (Vector Laboratories), and stained with Alexa Fluor® 488 Rat Anti-Mouse CD4 antibody (Cat. No. 557667, pseudo-colored blue), Alexa Fluor® 647 Rat Anti-Mouse CD8a antibody (Cat. No. 557682, pseudo-colored red), and Biotin Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553085). After washing, sections were then stained with BD Horizon™ BV421 Streptavidin secondary reagent (Cat. No. 563259, pseudo-colored green). Images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and CompBead to ensure that BD Comp beads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
BD Horizon™ BV421 Streptavidin is a useful second-step reagent for the indirect immunofluorescent staining of cells in combination with biotinylated primary antibodies for flow cytometric analysis.
Streptavidin is a non-glycosylated protein that is prepared chromatographically from the bacterium Streptomyces avidinii. Streptavidin homotetramers have a particularly high, non-covalent binding affinity for biotin. When conjugated with fluorochromes, streptavidin has been widely used with biotin-conjugated antibodies and other biotinylated specific-binding molecules (eg, recombinant proteins and lectins) to stain cells and tissues for subsequent multiparameter analysis by flow cytometry, fluorescence microscopy and imaging. Likewise, when conjugated with an enzyme (eg, Horseradish Peroxidase or Alkaline Phosphatase) and coupled with a colorimetric or luminescent substrate development system, streptavidin has found widespread use along with biotinylated antibodies in a number of applications including Western blot, ELISA, ELISPOT, immunocytochemistry and immunohistochemistry.
Streptavidin was conjugated to BD Horizon BV421 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max near 407 nm and Em Max near 421 nm, BD Horizon BV421 can be excited by the violet laser (405 nm) and detected with a 450/50 nm filter. BD Horizon BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific BlueTM conjugates. Due to nearly identical excitation and emission properties but different spillover characteristics, BD Horizon BV421, Pacific Blue, and BD Horizon V450 cannot be used simultaneously.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.
Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.